Evidence map›Paper›PMID 41188546›Full record

ArticleCommunications biology2025

A zebrafish model of chronic heart failure caused by protein aggregation in heart valves.

Yitong Li, Shingo Maegawa, Ryo Kimura, Shiho R Suzuki, Taiki Nishimura, Masatoshi Hagiwara

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yitong LiDepartment of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shingo MaegawaDepartment of Intelligence Science and Technology, Graduate School of Informatics, Kyoto University, Kyoto, Japan.
Ryo KimuraDepartment of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. kimura.ryo@ugscd.osaka-u.ac.jp.ORCID http://orcid.org/0000-0003-3220-991X
Shiho R SuzukiDepartment of Child Development, United Graduate School of Child Development, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0009-0004-9799-604X
Taiki NishimuraDepartment of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Masatoshi HagiwaraDepartment of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-7079-4788

Funding

MEXT | Japan Science and Technology Agency (JST) JPMJSP2110MEXT | Japan Society for the Promotion of Science (JSPS) 21H05042MEXT | Japan Society for the Promotion of Science (JSPS) 21H05326MEXT | Japan Society for the Promotion of Science (JSPS) 22H00986MEXT | Japan Society for the Promotion of Science (JSPS) 23H03883
6 · The paper itself

Abstract

We previously developed a unique zebrafish, tomato, expressing the red fluorescent protein DsRed under the control of the tph2 promoter. Unexpectedly, the tomato fish showed cardiac dilation and symptoms resembling those of chronic heart failure. Therefore, we investigate the pathogenesis and causes of these cardiac abnormalities. Crossbreeding suggests a link between DsRed expression and heart enlargement. Histological analysis confirms atrial dilation and thickening of the atrioventricular valve. RNA sequencing and immunohistological imaging reveal that valve thickness is due to the upregulated inflammation, cell proliferation, and epithelial-mesenchymal transition. Importantly, immunohistological staining elucidates DsRed accumulation in the atrioventricular valve, and removal of DsRed via Cre-mRNA injection rescues these heart defects. This study establishes a potential model of heart failure caused by protein aggregation in the cardiac valve. These findings highlight the potential of this transgenic zebrafish for investigating valvular heart diseases and chronic heart failure and developing new therapies.

Indexed as

Heart FailureHeart ValvesProtein AggregatesZebrafishAnimalsAnimals, Genetically ModifiedChronic DiseaseDisease Models, AnimalLuminescent ProteinsLuminescent ProteinsProtein Aggregates

Identifiers

PMID41188546
PMCPMC12586624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.